SCHEMBL1369445

SCHEMBL1369445

NC(=O)c1cnccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
CHUK O15111 1/20 0.55
KDM4E B2RXH2 7/20 0.50
ALDH1A1 P00352 4/20 0.50
MAPT P10636 2/20 0.50
TSHR P16473 2/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 1/20 0.50
MKNK1 Q9BUB5 4/20 0.49
MKNK2 Q9HBH9 4/20 0.49
HTT P42858 1/20 0.46
F7 P08709 1/20 0.45
F3 P13726 1/20 0.45
SARM1 Q6SZW1 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
SIRT6 Q8N6T7 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
SIRT5 Q9NXA8 1/20 0.45
SIRT4 Q9Y6E7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4598141 0.98 SIRT3 (0.60) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL2645253 0.83 TDP1 (0.57) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL1687197 0.82 TDP1 (0.67) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL1330970 0.82 TDP1 (0.67) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL17438491 0.81 TDP1 (0.55) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL17438485 0.81 TDP1 (0.55) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL30804202 0.80 KDM4C (0.55) SIRT3TDP1KDM4EALDH1A1MAPT
SCHEMBL852353 0.80 KDM4C (0.55) SIRT3TDP1KDM4EALDH1A1MAPT
SCHEMBL310266 0.78 TDP1 (0.62) SIRT3TDP1CHUKKDM4EALDH1A1
SCHEMBL19838598 0.78 TDP1 (0.47) SIRT3TDP1CHUKKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118453653-A Hair growth composition containing hair follicle repairing protein composition, and preparation method and application thereof 达尔文新研(北京)生物科技有限公司 2024-08-09 CN claimed
EP-3600312-B1 PIPERIDINYL- AND PIPERAZINYL-SUBSTITUTED HETEROAROMATIC CARBOXAMIDES AS MODULATORS OF GPR6 TAKEDA PHARMACEUTICALS CO (JP) 2023-05-17 EP claimed
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20250129044-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2025-04-24 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-20230101819-A1 SMYD Inhibitors EPIZYME INC (US) 2023-03-30 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
WO-2022170075-A1 AUXINIC HERBICIDES AND METHODS OF USE THEREOF CORTEVA AGRISCIENCE LLC (US) 2022-08-11 WO disclosed
US-11377439-B2 Heterocyclic prolinamide derivatives Orion Ophthalmology LLC (US) 2022-07-05 US disclosed
US-20080255222-A1 PHARMACEUTICALLY ACTIVE BENZSULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2008-10-16 US disclosed
US-20080207590-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2008-08-28 US disclosed
US-7417058-B2 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases LABORATOIRES SERONO S.A. (CH) 2008-08-26 US disclosed
US-20070213316-A1 Compounds that are effective inhibitors of beta-secretase; inhibitors of beta-secretase-mediated cleavage of amyloid precursor proteins; effective inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques; treatment of disorders such as Alzheimer's Disease ELAN PHARMACEUTICALS, INC. 2007-09-13 US disclosed
US-7176242-B2 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARMACEUTICALS, INC. (US) 2007-02-13 US disclosed
US-20040224918-A1 Anti-mycobacterial compounds YATVIN MILTON B (US) 2004-11-11 US disclosed
US-6689760-B1 ANALOGS FOR NICOTINAMIDE ADENINE DINUCLEOTIDE; TUBERCULOSIS ENZREL INC. 2004-02-10 US disclosed
WO-2002004478-A1 ANTI-MYCOBACTERIAL COMPOUNDS ENZREL, INC. (US) 2002-01-17 WO disclosed
US-4925859-A Novel 4-hydroxy-3-pyridine-carboxamides useful for treating inflammation and rheumatism ROUSSEL UCLAF (FR) 1990-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129044-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS SCN1B, SCN1A, SCN2B SIRT3 760/4885TDP1 1890/4885CHUK 797/4885
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SIRT3 3239/4885TDP1 1383/4885CHUK 743/4885
US-20040224918-A1 Anti-mycobacterial compounds IMMT, PML, TBC1D5 SIRT3 930/4885TDP1 3716/4885CHUK 1190/4885
US-20080207590-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC11 SIRT3 103/4885TDP1 1331/4885CHUK 201/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SIRT3 3239/4885TDP1 1383/4885CHUK 743/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK SIRT3 3473/4885TDP1 1153/4885CHUK 964/4885
US-20080255222-A1 PHARMACEUTICALLY ACTIVE BENZSULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES MAP3K5, MAP3K2, MAP3K21 SIRT3 1964/4885TDP1 2292/4885CHUK 25/4885
US-20230101819-A1 SMYD Inhibitors SMYD3, SMYD2, SMURF2 SIRT3 3116/4885TDP1 1739/4885CHUK 214/4885
US-11377439-B2 Heterocyclic prolinamide derivatives HTRA1, ALDH1A2, HTRA2 SIRT3 315/4885TDP1 306/4885CHUK 862/4885
US-20070213316-A1 Compounds that are effective inhibitors of beta-secretase; inhibitors of beta-secretase-mediated cleavage of amyloid precursor proteins; effective inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques; treatment of disorders such as Alzheimer's Disease BACE1, BACE2, APP SIRT3 354/4885TDP1 127/4885CHUK 1008/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR SIRT3 3316/4885TDP1 1012/4885CHUK 477/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SIRT3 3239/4885TDP1 1383/4885CHUK 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.